Critical Challenges and Landmark Practice Advances in Management of STEMI and High Risk ACS

Critical Challenges and Landmark Practice Advances in Management of STEMI and High Risk ACS Challenging Conventional Wisdom in the Catheterization Laboratory
Select Session click below to choose a session for viewing for webcast help click here

Challenging the Conventional Wisdom of STEMI and High Risk ACS Care in the Catheterization Laboratory Moving into a New Era of Interventional Care (Program Chairman) Sunil V. Rao, MD, FACC

New Paradigms of Care for STEMI Focusing on Mortality and Attributable Death Analysis What Do Device and Drug Trials Teach Us? Gregg W. Stone, MD, FACC

Connecting Evidence Across All the Trials and Streams: Why Bleeding and Ischemia Both Matter Is a Unified and Consistent Intervention-Based Strategy Achievable Across the Entire Risk Continuum for STEMI and High Risk ACS? Sunil V. Rao, MD, FACC

Does “Switching” From Enoxaparin or Unfractionated Heparin to Bivalirudin Monotherapy Result in a Bleeding Benefit? Ron Waksman, MD, FACC

Translating Advances in STEMI and High Risk ACS Management Into Real World Interventional Cardiology Practice Harold L. Dauerman, MD

Question and Answer Session Faculty Panel

Challenging Conventional Wisdom in the Catheterization Laboratory